About Stellargene Technologies Private Limited
Data last updated: 21 July 2025
Stellargene Technologies Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It specialised in other hospital and medical care activities, a part of the broader healthcare sector. Incorporated on 06 December 2016.
Registered with ROC Delhi under CIN U74999DL2016PTC308908.
Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.25 Lakh. It was led by directors Bhagwati Sharan Tiwary and Ashutosh Pastor.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Room No 1 Tbiu Indian Institute Of Tech. Delhi, 2Nd Flr Synergy Bldg Tbiu Complex Iit Delhi, New Delhi, Delhi, India – 110016.
As per the financials filed for FY 2017, the company reported a revenue of ₹43,000.
The company was associated with 1 brand - Stellargene.
The company is no longer operational and has been struck off from the Register of Companies, typically due to non-filing of annual returns or failure to commence business. Entering into any agreement with a struck-off entity carries significant legal and financial risk. The last known website on record is stellargene.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressRoom No 1 Tbiu Indian Institute Of Tech. Delhi, 2Nd Flr Synergy Bldg Tbiu Complex Iit Delhi, New Delhi, Delhi, India – 110016
-
IndustryHealthcare, Other Hospital And Medical Care Activities
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Stellargene Technologies Private Limited
Stellargene Technologies Private Limited operates one associated brand: StellarGene. These brands represent Stellargene Technologies Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Provides comprehensive genetic testing solutions for accurate gene analysis and personalized health insights. | stellargene.com |
Competitors & Alternatives of Stellargene Technologies Private Limited
Brands and companies operating in the same space as Stellargene Technologies Private Limited include 23andMe, Helix, DDC Paternity Tests and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
23andMe
|
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | Sunnyvale, United States, United States | 2006 |
Helix
|
Genomic database for clinical research is provided. | San Francisco, United States, United States | 2015 |
DDC Paternity Tests
|
DNA tests and personalized diagnostics are provided for various specialties. | Fairfield, United States, United States | 1995 |
MapMyGenome
|
Personal genetic testing and diagnostics services are provided. | Hyderabad, India, India | 2013 |
EONE Diagnomics Genome Center
|
Genomics-based diagnostic services are developed for health screening and assessment. | Incheon, South Korea, South Korea | 2013 |
Celemics
|
Novel sequencing technologies for NGS-based genome analysis are developed. | Seoul, South Korea, South Korea | 2010 |
Asa Rén
|
AI-powered platform for precision medicine and longevity research is developed. | Jakarta, Indonesia, Indonesia | 2020 |
23Mofang
|
Provides genetic testing services to help prevent potential problems and early intervention. | Chengdu, China, China | 2015 |
Vitagene
|
Personalized supplement recommendations are generated from genomic and health data. | San Francisco, United States, United States | 2014 |
Made of Genes
|
Genomics platform for acquiring, storing, and sharing personal genomic information | Barcelona, Spain, Spain | 2015 |
Business Activity of Stellargene Technologies Private Limited
Stellargene Technologies Private Limited operates primarily in the hospital and medical care sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| ********* | Hospital and Medical Care | ********* | Other Hospital and Medical Care Activities | ********* |
Auditor Details of Stellargene Technologies Private Limited
Stellargene Technologies Private Limited is audited by SUMIT S KUMAR & CO for the financial year 2017. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SUMIT S KUMAR & CO | blur-value | blur-value | blur-value |
Board of Directors of Stellargene Technologies Private Limited
Stellargene Technologies Private Limited is currently managed by 2 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhagwati Sharan Tiwary | Director | 20 May 2023 | 3 Years 1 Months | As last reported |
| Ashutosh Pastor | Director | 20 May 2023 | 3 Years 1 Months | As last reported |
Financials of Stellargene Technologies Private Limited FY 2024 filings available
Stellargene Technologies Private Limited reported revenue of ₹43,000 (up ) for FY 2017. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Stellargene Technologies Private Limited
As of FY 2017, Stellargene Technologies Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings Stellargene Technologies Private Limited
Stellargene Technologies Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Stellargene Technologies Private Limited
View historical data on people associated with Stellargene Technologies Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Stellargene Technologies Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Stellargene Technologies Private Limited
GSTIN & GST Filing Data of Stellargene Technologies Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Stellargene Technologies Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Stellargene Technologies Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Stellargene Technologies Private Limited
MSME Payment Delays by Stellargene Technologies Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Stellargene Technologies Private Limited
Subsidiaries & Group Companies of Stellargene Technologies Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Stellargene Technologies Private Limited with ownership details.
MCA Filings & Documents of Stellargene Technologies Private Limited
MCA Filings & Documents of Stellargene Technologies Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Stellargene Technologies Private Limited
Frequently Asked Questions about Stellargene Technologies Private Limited
Stellargene Technologies Private Limited has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Stellargene Technologies Private Limited is a struck-off private limited company in the healthcare sector based in New Delhi, Delhi, India. It was incorporated on 06 December 2016 and is registered under CIN U74999DL2016PTC308908. The company has been struck off by the Registrar of Companies and is no longer operational.
The current directors of Stellargene Technologies Private Limited are:
The CIN (Corporate Identification Number) of Stellargene Technologies Private Limited is U74999DL2016PTC308908. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The primary industry of Stellargene Technologies Private Limited is healthcare. The company specifically operates in other hospital and medical care activities. The company was active in this sector before being struck off.
The company has its registered office at Room No 1 Tbiu Indian Institute Of Tech. Delhi, 2Nd Flr Synergy Bldg Tbiu Complex Iit Delhi, New Delhi, Delhi, India – 110016.